🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effects of Remote Ischaemic Preconditioning in Cemented Hip Arthroplasty.

RecruitingNAAges 65 Years - 90 YearsAllUniversity of Tartu
NCT06323018 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Total joint arthroplasty is one of the best treatment options for end-stage osteoarthritis. Cemented hip arthroplasty is mainly indicated for elderly patients with poor bone quality and multiple comorbidities. Bone cement implantation syndrome is associated with cemented hip arthroplasty and it has been shown to increase cardiovascular and renal complication and brain damage postoperatively. The aim of this project is to elucidate whether remote-ischemic preconditioning (RIPC) has multi-organ protective effect in cemented hip arthroplasty patients.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * age \>65 years * undergoing total hip cemented hip arthroplasty Exclusion Criteria: * previously diagnosed peripheral artery disease on both upper limb * RIPC is contraindicated
💊

What it tests

  • Remote Ischemic Preconditioning
  • SHAM
📍

Where

1 site
University of Tartu
Tartu, Estonia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy